Soc. Generale Knock-Out VLK/ DE000SU9W8Q8 /
2024-11-08 10:07:48 AM | Chg.+0.01 | Bid5:40:03 PM | Ask5:40:03 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
3.43EUR | +0.29% | - Bid Size: - |
- Ask Size: - |
Van Lanschot Kempen ... | 24.692 EUR | 2078-12-31 | Call |
GlobeNewswire
06-26
Zealand Pharma announces completion of an upsized equity offering of 8.35 million new ordinary share...
GlobeNewswire
06-25
Zealand Pharma announces upsizing of previously announced equity offering from approximately USD 900...
GlobeNewswire
06-25
Zealand Pharma launches equity offering of new shares raising gross proceeds of approximately USD 90...
GlobeNewswire
03-04
Valneva to Present at Upcoming TD Cowen and Van Lanschot Kempen Healthcare Investor Conferences
GlobeNewswire
02-29
MoonLake Immunotherapeutics Reports Full Year 2023 Financial Results, Recent Business Highlights and...
GlobeNewswire
2023-12-22
Zealand Pharma enters into EUR 90 million finance agreement with the European Investment Bank
GlobeNewswire
2023-10-10
Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors
GlobeNewswire
2021-02-09
SEQUANA MEDICAL SUCCESSFULLY RAISES EUR 22.5 MILLION IN AN EQUITY PLACEMENT
GlobeNewswire
2020-06-26
Hyloris Pharmaceuticals Raises approximately EUR 61.81 million in Successful Initial Public Offering
GlobeNewswire
2020-06-24
Hyloris Pharmaceuticals Announces Narrowing of Price Range of its Initial Public Offering
GlobeNewswire
2020-06-19
Hyloris Pharmaceuticals Announces Coverage of the Maximum Offering Size, including Increase Option a...
GlobeNewswire
2020-06-18
Hyloris Pharmaceuticals Announces the Coverage of the Base Offering Throughout the Price Range of it...
GlobeNewswire
2020-06-17
Hyloris Pharmaceuticals launches its Initial Public Offering on Euronext Brussels
GlobeNewswire
2020-06-03
Hyloris Pharmaceuticals Announces Intention to Launch an Initial Public Offering on Euronext Brussel...
GlobeNewswire
2020-01-22
Sequana Medical Successfully Raises Eur 19.0 Million in an Equity Placement